Some of the synthesized derivatives likely exhibited the ability to activate the CB1 receptor, as suggested by our experimental model, considering that it has been well established that CB1 and CB2 receptor activation by agonists induces cell death and inhibits tumor cell growth. This evidence concerns the gene CNR1 and neoplasm.